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INTRODUCTION & BACKGROUND
Abstract: The underlying problem for two of
the three most common patterns of
unexpected hospital deaths (PUHD) is
hypoventilation1. Current methods of postoperative respiratory monitoring give
delayed signals and have a high false
positive rate leading nurses to ignore
alarms. We hypothesize there exists a
combination of low cost sensors which are
capable of providing real time feedback and
alarms regarding obstructive sleep apnea
and ventilatory depression. Such a monitor
would be useful during space travel when
monitoring personnel are limited following
an injury or if astronauts were to be sedated
during extended travel. Methods: Twenty-six
subjects were recruited to participate in a
study of the effects of Propofol and
Remifentanil. Throughout the day, these
patients were exposed to varying levels of
both drugs simultaneously via target
controlled infusions. These patients were
attached to breathing and oxygen monitors
including chest bands, pulse oximeters,
nasal pressure sensors, C02 capnography,
breathing microphones, and thermistors.
The patients were then observed for types
of apnea or ventilatory depression. Results:
The study is currently ongoing however
preliminary analyses of the data indicate
multiple low cost sensors are capable of
detecting respiratory rate as well as
obstructive events and apnea. Conclusion:
Using only a combination of low cost
sensors, we can provide real time
respiratory event data to nurses and
practitioners.

The underlying problem for two of the three
most common patterns of unexpected
hospital deaths (PUHD) is hypoventilation1.
Type II PUHD (CO2 narcosis) involves a
reduction in respiratory rate and/or tidal
volume, and if supplemental oxygen is
being provided, a pulse oximeter will not
detect the problem until the hypercarbia is
significantly advanced and the patient is
near respiratory arrest. Type III PUHD is
induced by obstructive sleep apnea in the
presence of arousal failure, and is
recognized as a repetitive sequence of
cyclic apneas and self-arousals which
precede the final apnea. A pulse oximeter
alarms with each apneic period and will
likely be interpreted as generating many
false positive alarms.1 The risk of opioidinduced
respiratory
depression
in
postoperative patients is greatest in the first
24 hours after initiation of opioids2, and
opioids are the most commonly used drug
for treating pain in the postoperative
period.3
These problems would be especially
apparent in space travel where monitoring
personnel are limited due to either sedation
of crew members or an injury rendering the
crew short-handed.
Respiratory depression is caused by druginduced inhibition of the breathing control
center of the brain stem. Partial to full
airway obstruction is an anatomic problem
involving the soft palate, tongue base,
and/or epiglottis, caused by drug-induced
decreases in airway patency and muscle
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tone. Sedatives and opioids depress the
response to elevated CO2 (reduced drive to
breathe), worsen arousal, cause airway
obstruction, and change sleep patterns4-8
In the postoperative period, most adverse
respiratory events occur during the first 24
hours of opioid administration.2 During this
period,
pulse
oximeter
monitoring,
supplemental oxygen, incentive spirometry,
and intermittent nursing observation are the
primary interventions used to fend off
adverse respiratory events. For inpatient
monitoring, pulse oximetry is often
inadequate. On a busy hospital floor, it is
difficult to respond to multiple remote
advisory pulse oximetry alarms. Pulse
oximeter alarms are ignored because they
have a high false-positive alarm rate due to
movement artifact and displacement.9,10
Pulse
oximetry
primarily
monitors
oxygenation instead of ventilation; the SpO2
signal is a delayed indicator for apnea or
hypopnea, particularly when supplemental
oxygen is given. By the time the pulse
oximeter alarms, an apneic patient is
already in danger of hypoxia, brain injury
and death.
Existing
technologies
may
improve
monitoring of adverse respiratory events in
this setting, but are either costly or difficult
to implement. For example, monitoring
ventilation with capnography is expensive
and it can be problematic to sample the
exhaled gas with a face mask or nasal
cannula
in
non-intubated
patients.11
Acoustic respiratory rate monitoring may be
able to detect airway obstruction, but it is
costly and may not have sufficient sensitivity
to
reliably
detect
apnea
events.12
Additionally, most modern devices have
been verified for the clinical setting where
patients are intubated and may not function
adequately in the non-intubated setting. We
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suggest that there is an urgent need for a
low cost, reliable respiratory depression
monitoring technique that can be integrated
with the signals from the pulse oximeter to
give additional physiologic information about
a patient’s sufficiency of both ventilation and
oxygenation in the non-intubated setting.
Currently, we are exploring the value of
integrating the information from a set of lowcost physiologic monitors that can be
adapted to monitoring patients in a hospital
floor setting. In addition to the red and
infrared component signals that comprise
the pulse oximeter plethysmography
waveform,
we
intend
to
integrate
information from respiratory inductance
plethysmography sensors on the body,
temperature, pressure and carbon dioxide
sensors embedded in a nasal cannula and
acoustic respiratory rate via a microphone
on the throat. We will determine from the
tested set the fewest number and least
costly types of sensors that can be used to
accurately identify and quantify ventilatory
depression and airway obstruction, provide
reliable measures of oxygenation AND
ventilation, provide specific alarms, and
avoid artifact. We will evaluate this multisensor set for volunteers who receive
medications
to
produce
ventilatory
depression and/or partial to complete airway
obstruction.
Our team previously characterized various
effects of sedatives combined with opioids
using drug interaction models. Specifically,
we characterized the interaction of Propofol
and Remifentanil on metrics of airway
obstruction and intolerable ventilatory
depression in volunteers.8 We defined
intolerable ventilatory depression as a
respiratory rate less than 6 breaths per
minute and airway compromise as either
partial (tidal volume less than 3 mL/kg in the

3

2017 Rocky Mountain Space Grant Consortium

presence of a respiratory effort) or complete
obstruction. Respiratory compromise was
defined as either intolerable ventilatory
depression or airway obstruction or both.
Using this model, predictions of respiratory
compromise (0 to 100%) can be made for
various dosing schemes of Propofol and
remifentanil.8 (Figure 1). In general, dosing
schemes that led to high concentration of
Propofol were more likely to produce airway
obstruction
and
higher
doses
of
Remifentanil were more likely to produce
intolerable ventilatory depression.

Figure 1: A: Dose of a drug over time. B: effect
site concentration (Ce) Corresponding to the
given dose and C: Observed effect (sedation) for
a single administered drug. Time points 1-5
correspond to a different effects on respiration

METHODS
A 20 gauge venous catheter was placed in
an antecubital vein under local anesthesia
(0.2 mL of 0.5% lidocaine) for the purpose
of hydration and drug administration. The
IV site was similar in all subjects. A
maintenance infusion of 0.9% sodium
chloride was administered at 1 ml/kg/hour
throughout the study. Continuous infusions
of Remifentanil and Propofol was infused
into this peripheral IV.
Subjects were instrumented with a
noninvasive blood pressure cuff, ECG
leads, pulse oximeter(s), motion sensors,
respiratory inductance plethysmography
"chest bands", capnography nasal cannula,
nasal gas pressure sensor, nasal thermistor
and an acoustic respiratory rate sensor.
These or similar monitors were placed to
measure respiratory rate, tidal volume, endtidal CO2, SpO2, blood pressure, body
motion and heart rate. Chest and abdominal
wall excursion were measured with the
attached motion sensors and the respiratory
inductance
plethysmography
bands.
Changes in respiration pattern were
displayed as real-time changes in CO2
waveforms. A processed EEG monitor
and/or a cerebral oximeter were optionally
placed to record data for later analysis. A
motion sensor was also placed on the bed.
These devices were operational during the
entire study day. Data from devices was
electronically captured and recorded for
later analysis. Continuous variables such as
motion
waveforms,
pulse
oximetry
waveform, capnogram, and nasal airway
pressure were digitized during data
collection periods at 50-1000Hz during data
collection periods at each target effect site
concentration pair. Discrete variables were
recorded every 5 seconds or as soon as
data were available during data collection
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periods. Examples of discrete variables
include heart rate, SpO2, PetCO2, systolic
blood pressure, diastolic blood pressure and
respiratory rate. The tidal volume was
occasionally measured with a differential
pressure flow sensor attached to an
anesthesia mask or mouthpiece in order to
calibrate
the
respiratory
inductance
plethysmography bands.
Each subject received Propofol and
Remifentanil. Similar to previously collected
data from our volunteer laboratory (Kern et
al, 2004), each drug was administered using
a
computer
controlled
(Stanpump14)
continuous infusion pump (Pump 22;
Harvard Apparatus, Limited, Holliston, MA)
to achieve selected target effect site
concentrations.
The
effect
site
concentration
refers
to
the
drug
concentration at the pharmacologic site of
action. Pharmacokinetic
parameters
15
published by Minto et al. and Schnider et
al.16 was used for Remifentanil and Propofol
respectively.
We administered Propofol and Remifentanil
pairs in a dose escalation scheme with
small steps in order to creep up to the
desired target effects of respiratory
depression, airway obstruction and both
effects while avoiding overshoot. To
accomplish this, the Propofol was dosed in
a range of 0.75 - 4 mcg/mL in dose
escalation steps of approximately 0.5
mcg/mL. Remifentanil was dosed in a range
of 0.75 to 4.0 ng/mL in escalation steps of
approximately 0.25-0.5 ng/mL. If overshoot
was observed for a given target effect site
concentration pair, the target effect site
concentrations
were
lowered
so
assessments could be made during the
target effects of respiratory depression or
airway obstruction or both. Once the drug
concentration pair was identified which
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resulted in the target effects for a given
subject, the steady state drug dose was
maintained for a period of data collection.
In previous NASA space grant publications,
a preliminary analysis was performed on
these sensors which analyzed them for their
ability to detect obstructive and central
apneas denoted by a lack of signal. The
current aim of the project is to detect
specific breaths in each sensor and use
these breath marks to analyze periods of
low respiratory rates.
A custom breath detection algorithm was
developed which detects breaths in a signal
based on peaks which are above or below a
moving threshold. This algorithm works
functionally the same for each signal and
adapts based on specific thresholds which
were manually identified for each sensor.
Data were isolated from periods during
which the patient was unperturbed, not
talking, and breathing normally (no
obstruction present). This data was
segmented into individual minute-by-minute
segments. Segments which had more than
10 breaths in them (as counted by the
respiratory inductance plethysmography
bands) were excluded from the analysis.
Bland-Altman and linear regression analysis
were performed on the data in order to
analyze the confidence intervals for breath
rates. A sample Bland-Altman plot for the
capnogram is shown in figure 2.
The next analysis involved restricting the
data set even further to get an estimation of
how often the alarm would falsely report on
the patient condition at a clinically relvant
respiratory rate of 5 or fewer breaths—
commonly
diagnosed
as
‘ventilatory
depression’.
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Each signal was analyzed so that at each
respiratry rate less than or equal to 10, the
signal was compared against the reference
signal (RIP bands) and the number of times
that the signal was incorrectly diagnosing
‘ventilatory depression’ was counted.
An additional endeavor of this data set
analysis was extracting respiratory rate from
the photoplethysmography (PPG) signal
(pulse oximetry). An envelope filter was
used to obtain the baseline signal (related to
respiration) from the PPG. The RIP band
(as the reference respiratory rate signal)
and the PPG signal were analyzed in order
to explore the potential for using PPG to
monitor respiratory rate below 10 breaths
per minute (BPM). Examples of the filtered
signal are shown in figures 4, 5, and 6.
RESULTS
Figure 2 shows a sample of a Bland-Altman
analysis performed on the capnogram with
the RIP bands as the reference signal. The
signal shows no change in relative bias and
consistent deviation at all respiratory rates.
The x-axis represents the mean of
respiratory rates reported by the capnogram
and the RIP bands. The y-axis represents
the difference in the reported respiratory
rates.
Table 1 shows the relevant statistics from
the Bland-Altman analysis not only from the
capnogram but also from the thermistor and
impedance signals.
Figure 3 illustrates an analysis in which
sections of data were organized by breath
rate, and the observed percentage of
misdiagnosis (regarding a RR greater than,
or less than 5 BPM) was graphed. The
capnogram illustrated the lowest range of
misdiagnosis. The error of the impedance
monitor varied wildly with respiratory rate.

Figure 2: Bland-Altman plot of capnogram reported
breath rate versus RIP band breath rate. X-axis is the
mean of the reported breath rates and y-axis is the
difference (capnogram-RIP bands) in reported breath
rates. Bias and confidence intervals are depicted by
the indicated lines.

Table 2: Bland-Altman statistics from the impedance,
thermistor, and capnogram monitors. Upper and lower
confidence intervals are reported as Bias±1.96*STD
Capnography

Impedance

Thermistor

Bias (BPM)

0.18

0.64

0.51

Std (BPM)

1.18

3.96

2.09

Upper 95%
Confidence
Interval
(BPM)

2.5

8.39

4.61

Lower 95%
Confidence
Interval
(BPM)

-2.13

-7.12

-3.58
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Figure 3: The observed percentage that the
respiratory rate displayed by a given sensor was in
error about a low RR (BPM<=5) diagnosis. The right
side of the black vertical line is the observed
percentage that a sensor displayed a RR>5 when the
actual respiratory rate was <=5 (Missed alarm). The
opposite case (test RR<=5, actual RR>5) (False
alarm) is shown on the left side of the black vertical
line.
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Figure 4: A 20-second window of RIP bands, PPG
waveform, and an envelope filtered PPG waveform
are displayed at a RR of 20 BPM. The filtered PPG
signal modulates in time with inspiration and
expiration as confirmed by the RIP waveform.

The error of the thermistor was high around
5-6 breaths per minute but relatively low
elsewhere.
Figure 4 shows an example of an optimal
case for using the PPG signal to measure
respiratory rate. In this sample, the breath
rate is roughly 20 and the filtered PPG
signal almost exactly mirrors the RIP band
signal.
Figures 5 and 6 both illustrate some of the
issues that arise when trying to use the
same signal to detect low respiratory rates.
In both cases, the respiratory rate is 6 or
less. In figure 5, there is an additional peak
present between breaths identified by the
RIP bands. In figure 6, the filtered PPG
signal demonstrates much more noise than
the ‘optimal’ case and shows a situation in
which the PPG signal creates a doublepeak during a single breath identified by the
RIP bands.

Figure 5: A 20-second window of RIP bands, PPG
waveform, and an envelope filtered PPG waveform
are displayed at a RR of <5 BPM. The filtered PPG
waveform changes during the same time period as
the RIP waveform, but with multiple peaks.

Figure 6: A 20-second window of RIP bands, PPG
waveform, and an envelope filtered PPG waveform
are displayed at a RR of <5 BPM. The filtered PPG
signal has deflections between breaths indicated by
the RIP bands.
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CONCLUSION
A low cost, accurate, and minimally sized
respiratory monitor would be useful during
space travel when personnel are limited
following an injury/emergency procedure or
if astronauts were to be sedated during
extended voyages.
The primary goal of this analysis was to
identify the best way to analyze a signal for
its clinical utility and to test this analysis on
some sample signals.
Figure 3 showed a new method of analyzing
signals which relies on analyzing the
number of ‘false alarms’ that a sensor might
display when monitoring a patient. These
false alarms were specifically related to
clinically relevant low respiratory rates. The
logic behind this is that most monitors will
perform adequately in the range of ‘normal
breathing’ but may not perform adequately
when it comes to raising alarms. The
capnogram demonstrated that it has the
ability to distinguish between different
respiratory rates remarkably well at low
respiratory rates. The impedance monitor,
on the other hand, was subject to much
lower signal-to-noise ratio at these
respiratory rates and performed poorly with
respect to properly raising alarms.
This facet of signals performing differently at
different respiratory rates is highlighted by
the case of the PPG signal. At a respiratory
rate of 20 depicted in figure 4, the PPG
signal almost perfectly mimics the RIP
bands (which are used as the reference in
this study for their relatively high accuracy).
However when the respiratory rate becomes
low (less than 6 breaths per minute), the
signal becomes erratic and much more
susceptible to noise. A number of
physiological effects of respiration on the

bloodstream could be the reasoning behind
this. One of which is the sympathetically
mediated vasoconstriction which occurs at
high tidal volumes. These tidal volumes may
be more likely when the patient is breathing
intermittently and the vasoconstriction effect
may be more pronounced when there is
less of a respiration signal to mask it.
We intend to continue this analysis on a
number of different signals and analyze how
each signal performs specifically at the
clinically relevant respiratory rates we are
hoping to detect. Preliminary analysis
indicate that multiple sensors may be of use
in detecting these conditions.
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